Free Trial

BioRestorative Therapies (OTCMKTS:BRTXQ) Hits New 12-Month High - Time to Buy?

BioRestorative Therapies logo with Medical background

BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ - Get Free Report)'s share price hit a new 52-week high during trading on Monday . The company traded as high as $1.48 and last traded at $1.46, with a volume of 43606 shares. The stock had previously closed at $1.45.

BioRestorative Therapies Price Performance

The business has a 50 day moving average of $1.56 and a 200 day moving average of $1.61. The firm has a market capitalization of $2.39 billion, a price-to-earnings ratio of -1.36 and a beta of 102.36.

About BioRestorative Therapies

(Get Free Report)

BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in BioRestorative Therapies right now?

Before you consider BioRestorative Therapies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioRestorative Therapies wasn't on the list.

While BioRestorative Therapies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines